PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor

Neuropeptides

Volumn 48, Issue 2, 2014, Pages 53-64

  Jansen Olesen, Inger ^a   Baun, Michael ^a   Amrutkar, Dipak V ^a   Ramachandran, Roshni ^a   Christophersen, Daniel V ^a   Olesen, Jes ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Calcitonin gene related peptide; Nitric oxide synthase; Pituitary adenylate cyclase activating peptide; Trigeminal ganglion; Trigeminal nucleus; Vasoactive intestinal peptide

Indexed keywords

ADENYLATE CYCLASE; CALCITONIN GENE RELATED PEPTIDE; GLUTAMATE AMMONIA LIGASE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; MAXADILAN; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; POTASSIUM; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DURA MATER; ENZYME IMMUNOASSAY; GLIA CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION; ANIMAL; DRUG EFFECTS; METABOLISM; MIGRAINE; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DURA MATER; MALE; MIGRAINE DISORDERS; NITRIC OXIDE SYNTHASE TYPE II; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS, SPRAGUE-DAWLEY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; SIGNAL TRANSDUCTION; TRIGEMINAL GANGLION; TRIGEMINAL NUCLEI; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84896543074     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2014.01.004     Document Type: Article

References (47)

1. Arimura A. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn. J. Physiol. 1998, 48:301-331.
2. Baeres F.M., Moller M. Origin of PACAP-immunoreactive nerve fibers innervating the subarachnoidal blood vessels of the rat brain. J. Cereb. Blood Flow Metab. 2004, 24:628-635.
3. Baun M., Hay-Schmidt A., Edvinsson L., Olesen J., Jansen-Olesen I. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat. Eur. J. Pharmacol. 2011, 670:186-194.
4. Baun M., Pedersen M.H., Olesen J., Jansen-Olesen I. Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia 2012, 32:337-345.
5. Boni L.J., Ploug K.B., Olesen J., Jansen-Olesen I., Gupta S. The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery. Cephalalgia 2009, 29:837-847.
6. Chan K.Y., Baun M., de Vries R., van den Bogaerdt A.J., Dirven C.M., Danser A.H., Jansen-Olesen I., Olesen J., Villalon C.M., MaassenVanDenBrink A., Gupta S. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 2011, 31:181-189.
7. Chaudhary P., Baumann T.K. Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat. Brain Res. Mol. Brain Res. 2002, 104:137-142.
8. Christiansen T., Bruun A., Knight Y.E., Goadsby P.J., Edvinsson L. Immunoreactivity of NOS, CGRP, PACAP, SP and VIP in the trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2 of the cat. J. Headache Pain 2003, 4:156-163.
9. Csati A., Tajti J., Kuris A., Tuka B., Edvinsson L., Warfvinge K. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion. Neuroscience 2012, 202:158-168.
10. De Felice M., Ossipov M.H., Wang R., Dussor G., Lai J., Meng I.D., Chichorro J., Andrews J.S., Rakhit S., Maddaford S., Dodick D., Porreca F. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain 2010, 133:2475-2488.
11. Ebersberger A., Averbeck B., Messlinger K., Reeh P.W. Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 1999, 89:901-907.
12. Eftekhari S., Salvatore C.A., Calamari A., Kane S.A., Tajti J., Edvinsson L. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 2010, 169:683-696.
13. Ferry X., Brehin S., Kamel R., Landry Y. G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 2002, 23:1507-1515.
14. Grande G., Nilsson E., Edvinsson L. Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method. Cephalalgia 2013, 33:152-159.
15. Hanani M. Satelite glial cells in sensory ganglia: from form to function. Brain Res. Rev. 2005, 48:457-476.
16. Hannibal J., Mikkelsen J.D., Clausen H., Holst J.J., Wulff B.S., Fahrenkrug J. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul. Pept. 1995, 55:133-148.
17. Hashimoto H., Shintani N., Baba A. New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Ann. NY Acad. Sci. 2006, 1070:75-89.
18. Ho T.W., Mannix L.K., Fan X., Assaid C., Furtek C., Jones C.J., Lines C.R., Rapoport A.M. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008, 70:1304-1312.
19. Hundahl C.A., Allen G.C., Hannibal J., Kjaer K., Rehfeld J.F., Dewilde S., Nyengaard J.R., Kelsen J., Hay-Schmidt A. Anatomical characterization of cytoglobin and neuroglobin mRNA and protein expression in the mouse brain. Brain Res. 2010, 1331:58-73.
20. Jansen-Olesen I., Goadsby P.J., Uddman R., Edvinsson L. Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat. J. Auton. Nerv. Syst. 1994, 49(Suppl.):S97-103.
21. Jansen-Olesen I., Gulbenkian S., Engel U., Cunha e Sa, Edvinsson L. Peptidergic and non-peptidergic innervation and vasomotor responses of human lenticulostriate and posterior cerebral arteries. Peptides 2004, 25:2105-2114.
22. Kausz M., Arimura A., Koves K. Distribution and somatotopical localization of pituitary adenylate cyclase activating polypeptide (PACAP) in the trigeminal ganglion of cats and rats. Ann. NY Acad. Sci. 1998, 865:529-532.
23. Knutsson M., Edvinsson L. Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. NeuroReport 2002, 13:507-509.
24. Larsen J.O., Hannibal J., Knudsen S.M., Fahrenkrug J. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) in the mesencephalic trigeminal nucleus of the rat after transsection of the masseteric nerve. Brain Res. Mol. Brain Res. 1997, 46:109-117.
25. Lassen L.H., Ashina M., Christiansen I., Ulrich V., Grover R., Donaldson J., Olesen J. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 1998, 18:27-32.
26. Lassen L.H., Haderslev P.A., Jacobsen V.B., Iversen H.K., Sperling B., Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002, 22:54-61.
27. Lennerz J.K., Ruhle V., Ceppa E.P., Neuhuber W.L., Bunnett N.W., Grady E.F., Messlinger K. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J. Comp Neurol. 2008, 507:1277-1299.
28. Moller K., Zhang Y.Z., Hakanson R., Luts A., Sjolund B., Uddman R., Sundler F. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience 1993, 57:725-732.
29. Moller M., Baeres F.M. PACAP-containing intrapineal nerve fibers originate predominantly in the trigeminal ganglion: a combined retrograde tracing- and immunohistochemical study of the rat. Brain Res. 2003, 984:160-169.
30. Mulder H., Uddman R., Moller K., Zhang Y.Z., Ekblad E., Alumets J., Sundler F. Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience 1994, 63:307-312.
31. Nemeth J., Reglodi D., Pozsgai G., Szabo A., Elekes K., Pinter E., Szolcsanyi J., Helyes Z. Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience 2006, 143:223-230.
32. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol. Ther. 2008, 120:157-171.
33. Olesen J., Diener H.C., Husstedt I.W., Goadsby P.J., Hall D., Meier U., Pollentier S., Lesko L.M. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N. Engl. J. Med. 2004, 350:1104-1110.
34. Olesen J., Thomsen L.L., Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci. 1994, 15:149-153.
35. Pardutz A., Krizbai I., Multon S., Vecsei L., Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. NeuroReport 2000, 11:3071-3075.
36. Rahmann A., Wienecke T., Hansen J.M., Fahrenkrug J., Olesen J., Ashina M. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 2008, 28:226-236.
37. Ramachandran R., Bhatt D.K., Ploug K.B., Hay-Schmidt A., Jansen-Olesen I., Gupta S., Olesen J. Nitric oxide synthase, calcitonin gene-related peptide and inflammatory mechanisms are involved in GTN induced neuronal activation. Cephalalgia 2014, 34:136-147.
38. Sakashita Y., Kurihara T., Uchida D., Tatsuno I., Yamamoto T. Involvement of PACAP receptor in primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord. Br. J. Pharmacol. 2001, 132:1769-1776.
39. Schlechtweg P.M., Roder J., Fischer M.J., Neuhuber W., Messlinger K. Increase in NADPH-diaphorase-positive and neuronal NO synthase immunoreactive neurons in the rat spinal trigeminal nucleus following infusion of a NO donor-evidence for a feed-forward process in NO production involved in trigeminal nociception. Cephalalgia 2009, 29:566-579.
40. Schytz H.W., Birk S., Wienecke T., Kruuse C., Olesen J., Ashina M. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 2009, 132:16-25.
41. Syed A.U., Koide M., Braas K.M., May V., Wellman G.C. Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine. J. Mol. Neurosci. 2012, 48:574-583.
42. Thomsen L.L., Kruuse C., Iversen H.K., Olesen J. A nitric oxide donor (nitroglycerin) induces genuine migraine attacks. Eur. J. Neurol. 1994, 1:73-80.
43. Uddman R., Goadsby P.J., Jansen I., Edvinsson L. PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow. J. Cereb. Blood Flow Metab. 1993, 13:291-297.
44. Vandenabeele F., Creemers J., Lambrichts I. Ultrastructure of the human spinal arachnoid mater and dura mater. J. Anat. 1996, 189(Pt 2):417-430.
45. Wulf-Johansson H., Amrutkar D.V., Hay-Schmidt A., Poulsen A.N., Klaerke D.A., Olesen J., Jansen-Olesen I. Localization of large conductance calcium-activated potassium channels and their effect on calcitonin gene-related peptide release in the rat trigemino-neuronal pathway. Neuroscience 2010, 167:1091-1102.
46. Zhang Y., Danielsen N., Sundler F., Mulder H. Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation. NeuroReport 1998, 9:2833-2836.
47. Zhang Y., Malmberg A.B., Sjolund B., Yaksh T.L. The effect of pituitary adenylate cyclase activating peptide (PACAP) on the nociceptive formalin test. Neurosci. Lett. 1996, 207:187-190.